VVOS News and Press, Vivos Therapeutics Inc. From 08/13/25

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...

Vivos Therapeutics Inc. (VVOS) is expected to report $-0.39 for Q2 2025

2025-08-12 18:45:13 ET Vivos Therapeutics, Inc. (VVOS) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.09%. The average open to low on the day of earnings was -6.61%. The average open ...

2025-08-12 18:40:10 ET Vivos Therapeutics, Inc. (VVOS) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in VVOS stock price following earnings has averaged ±2.53% , with a median of 1.35%....

LITTLETON, Colo., July 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a pioneering medical technology company revolutionizing the treatment of obstructive sleep apnea (OSA) and snoring, today announced the appointme...

2025-07-01 14:30:44 ET Vivos Therapeutics Jumps 28% After Medicare Approval for Sleep Apnea Device Vivos Therapeutics, Inc. ( VVOS ) climbed 28.16% to lead the PRISM Emerging MedDevices Index after receiving approval from the Centers for Medicare & Medicaid Services for ...

2025-07-01 11:04:06 ET Vivos Therapeutics, Inc. (NASDAQ: VVOS) is one of today’s top gainers. The company’s shares have moved 30.26% on the day to $4.12. Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for pati...

2025-07-01 09:04:02 ET DENVER, Colo., Jul 01, 2025 ( 247marketnews.com )- Vivos Therapeutics (NASDAQ:VVOS) reported that the VidaSleep oral appliance has been officially approved by the Centers for Medicare & Medicaid Services (CMS) Pricing, Data Analysis and Coding (PDA...

LITTLETON, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a pioneering medical technology company revolutionizing the treatment of obstructive sleep apnea (OSA) and snoring, today announced that its Vi...

LITTLETON, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leader in proprietary, non-invasive treatments for obstructive sleep apnea (OSA), today announced that the European Journal of Pedia...